PDGF stimulation of Müller cell proliferation: Contributions of c-JNK and the PI3K/Akt pathway

Biochemical and Biophysical Research Communications

Volumn 388, Issue 1, 2009, Pages 167-171

  Moon, Sang Woong ^a   Chung, Eun Jee ^b   Jung, Sun Ah ^c   Lee, Joon H ^c  

^a Inje University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Konyang University College of Medicine   (South Korea)

Author keywords

Cell proliferation; M ller cell; Platelet derived growth factor; Proliferative vitreoretinopathy

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VITREORETINOPATHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTHRACENES; CELL PROLIFERATION; CHROMONES; ENZYME INHIBITORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED BN; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RETINA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 68949098374     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.144     Document Type: Article

References (34)

1. Hiscott P.S., Grierson I., Trombetta C.J., Rahi A.H., Marshall J., and McLeod D. Retinal and epiretinal glia - an immunohistochemical study. Br. J. Ophthalmol. 68 (1984) 698-707
2. Rentsch F.J. Preretinal proliferation of glial cells after mechanical injury of the rabbit retina. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 188 (1973) 79-90
3. Van Horn D.L., Aaberg T.M., Machemer R., and Fenzl R. Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am. J. Ophthalmol. 84 (1977) 383-393
4. Guidry C. Tractional force generation by porcine Muller cells. Development and differential stimulation by growth factors. Invest. Ophthalmol. Vis. Sci. 38 (1997) 456-468
5. Guidry C., Bradley K.M., and King J.L. Tractional force generation by human muller cells: growth factor responsiveness and integrin receptor involvement. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1355-1363
6. Tallquist M., and Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev. 15 (2004) 205-213
7. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269 (1994) 32023-32026
8. Heldin C.H., Wasteson A., and Westermark B. Platelet-derived growth factor. Mol. Cell. Endocrinol. 39 (1985) 169-187
9. Ryan S.J. Retina (2006), Elsevier/Mosby, Philadelphia/Great Britain
10. Liang Y., Li X., Fan J., Zhao M., and Jiang Y. The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy. Zhonghua Yan Ke Za Zhi 38 (2002) 144-147
11. Robbins S.G., Mixon R.N., Wilson D.J., Hart C.E., Robertson J.E., Westra I., Planck S.R., and Rosenbaum J.T. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3649-3663
12. Andrews A., Balciunaite E., Leong F.L., Tallquist M., Soriano P., Refojo M., and Kazlauskas A. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2683-2689
13. Cassidy L., Barry P., Shaw C., Duffy J., and Kennedy S. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br. J. Ophthalmol. 82 (1998) 181-185
14. Ikuno Y., Leong F.L., and Kazlauskas A. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3107-3116
15. Milenkovic I., Weick M., Wiedemann P., Reichenbach A., and Bringmann A. P2Y receptor-mediated stimulation of Muller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1211-1220
16. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., and Iwao H. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 795-801
17. Thomas J.E., Venugopalan M., Galvin R., Wang Y., Bokoch G.M., and Vlahos C.J. Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase. J. Cell. Biochem. 64 (1997) 182-195
18. Zhang H., Bajraszewski N., Wu E., Wang H., Moseman A.P., Dabora S.L., Griffin J.D., and Kwiatkowski D.J. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J. Clin. Invest. 117 (2007) 730-738
19. Hicks D., and Courtois Y. The growth and behaviour of rat retinal Muller cells in vitro. 1. An improved method for isolation and culture. Exp. Eye Res. 51 (1990) 119-129
20. Chen K.C., Zhou Y., Zhang W., and Lou M.F. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells. Mol. Vis. 13 (2007) 374-387
21. Ishizawa K., Izawa-Ishizawa Y., Ohnishi S., Motobayashi Y., Kawazoe K., Hamano S., Tsuchiya K., Tomita S., Minakuchi K., and Tamaki T. Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells. J. Pharmacol. Sci. 109 (2009) 257-264
22. Vij N., Sharma A., Thakkar M., Sinha S., and Mohan R.R. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Mol. Vis. 14 (2008) 1020-1027
23. 2 generation and cell proliferation in human umbilical vein endothelial cells. Endothelium 15 (2008) 175-188
24. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
25. Kim T.J., and Yun Y.P. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Vascul. Pharmacol. 46 (2007) 43-51
26. Hollborn M., Bringmann A., Faude F., Wiedemann P., and Kohen L. Signaling pathways involved in PDGF-evoked cellular responses in human RPE cells. Biochem. Biophys. Res. Commun. 344 (2006) 912-919
27. Wang M.C., Bohmann D., and Jasper H. JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. Dev. Cell 5 (2003) 811-816
28. Kang Y.J., Jeon E.S., Song H.Y., Woo J.S., Jung J.S., Kim Y.K., and Kim J.H. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J. Cell. Biochem. 95 (2005) 1135-1145
29. Das A.V., Mallya K.B., Zhao X., Ahmad F., Bhattacharya S., Thoreson W.B., Hegde G.V., and Ahmad I. Neural stem cell properties of Muller glia in the mammalian retina: regulation by Notch and Wnt signaling. Dev. Biol. 299 (2006) 283-302
30. Lawrence J.M., Singhal S., Bhatia B., Keegan D.J., Reh T.A., Luthert P.J., Khaw P.T., and Limb G.A. MIO-M1 cells and similar muller glial cell lines derived from adult human retina exhibit neural stem cell characteristics. Stem Cells 25 (2007) 2033-2043
31. Nickerson P.E., Da Silva N., Myers T., Stevens K., and Clarke D.B. Neural progenitor potential in cultured Muller glia: effects of passaging and exogenous growth factor exposure. Brain Res. 1230 (2008) 1-12
32. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
33. Manning A.M., and Davis R.J. Targeting JNK for therapeutic benefit: from junk to gold?. Nat. Rev. Drug Discov. 2 (2003) 554-565
34. Kavurma M.M., and Khachigian L.M. ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. J. Cell. Biochem. 89 (2003) 289-300